Loading clinical trials...
Loading clinical trials...
An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study Between Two 5-mg Tablets and a New 10-mg Tablet Formulation of Lecozotan SR in Healthy Subjects.
To determine the bioequivalence between two 5-mg tablets of lecozotan and the new 10-mg tablet of lecozotan.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
Yes
Neuss, Germany
Start Date
June 1, 2007
Completion Date
June 1, 2007
Last Updated
December 5, 2007
40
Estimated participants
lecozotan SR
DRUG
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT04123314
NCT07178210
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions